摘要 |
<p>The present invention provides a compound of formula (I), as described herein, and pharmaceutically acceptable salts, enantiomers, rotamers, tautomers, or racemates thereof. Also provided are methods of treating a disease or condition mediated by PIM kinase using the compounds of Formula I, and pharmaceutical compositions comprising such compounds.</p> |
申请人 |
NOVARTIS AG;BURGER, MATTHEW;DING, YU;HAN, WOOSEOK;NISHIGUCHI, GISELE;RICO, ALICE;SIMMONS, ROBERT LOWELL;TANNER, HUW;WAN, LIFENG |
发明人 |
BURGER, MATTHEW;DING, YU;HAN, WOOSEOK;NISHIGUCHI, GISELE;RICO, ALICE;SIMMONS, ROBERT LOWELL;TANNER, HUW;WAN, LIFENG |